Icu Medical Inc/de 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
ICU Medical reported a net income of $0.732 million for fiscal year 2025, a significant improvement from prior losses, driven by strategic divestitures and gross margin expansion, despite a revenue decline and ongoing FDA regulatory challenges.
NASDAQ
ICU Medical's 2024 10-K filing reveals a complex financial landscape, marked by strategic acquisitions, global economic challenges, and ongoing efforts to optimize operations and navigate regulatory hurdles.
NASDAQ
ICU Medical's 2023 10-K filing reveals a complex financial landscape marked by global economic pressures, strategic integration efforts, and regulatory compliance in the medical device industry.